Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 09/09/2024 pm IST			5-day change	1st Jan Change
887.00 ^DKK	+0.62%		-4.53%	+27.06%

06/09	European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Index Set to End Week 3.7% Lower	MT
06/09	Novo Nordisk to present advances in diabetes treatment	CF

NOVO NORDISK : JP Morgan keeps its Buy rating

July 31, 2024 at 05:31 pm IST

In a research note published by Richard Vosser, JP Morgan advises its customers to buy the stock. The target price is unchanged at DKK 950.

Latest news about Novo Nordisk A/S

European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Index Set to End Week 3.7% Lower	06/09	MT
Novo Nordisk to present advances in diabetes treatment	06/09	CF
Are thematic ETFs useless?	06/09
Veeva Systems: leader in cloud solutions for the life sciences industry	06/09
NOVO NORDISK : Gets a Neutral rating from Berenberg	06/09	ZD
Health Care Declines as Risk Aversion Weighs - Health Care Roundup	06/09	DJ
European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading	05/09	MT
NOVO NORDISK : JP Morgan remains its Buy rating	05/09	ZD
How to find and check an Ozempic batch number	05/09	RE
Ozempic shortages will hit some EU countries only - Novo Nordisk	04/09	RE
Ozempic shortages in EU will not affect all member states - Novo Nordisk	04/09	RE
US will still pay at least twice as much after negotiating drug prices	03/09	RE
Novo Nordisk's Ozempic shortage expected to continue into Q4	02/09	RE
Biden Commends Eli Lilly for Cheaper Zepbound Version, Vows to Negotiate Lower Obesity Drug Prices	28/08	MT
NOVO NORDISK : Deutsche Bank keeps its Buy rating	28/08	ZD
Eli Lilly sells cheaper Zepbound option to meet demand	27/08	RE
Lilly launches single-dose vials of Zepbound for weight loss to expand US supply	27/08	RE
Analysis-Ozempic on Wall Street's list for 2027 Medicare drug negotiations	23/08	RE
Health Care Ticks Up on Defensive Bias - Health Care Roundup	23/08	DJ
Sector Update: Health Care Stocks Edge Up Late Afternoon	22/08	MT
Sector Update: Health Care Stocks Rise Wednesday Afternoon	21/08	MT
Global markets live: Novo Nordisk, Walmart, Target, Keysight Technologies, Coty...	21/08
European Equities Traded in the US as American Depositary Receipts Trend Slightly Higher in Wednesday Trading	21/08	MT
Sesame to Offer Novo Nordisk's Wegovy 'With No Retail Markup'	21/08	MT
Sesame to Offer Customers Novo Nordisk's Wegovy at Lowered Price	21/08	MT

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).

Employees

69,260

Sector

Pharmaceuticals

Calendar

06/11/2024 - Q3 2024 Earnings Release

Related indices

STOXX Europe 600 Index (EUR)

More about the company